We use some essential cookies to make this website work.
We’d like to set additional cookies to understand how you use GOV.UK, remember your settings and improve government services.
We also use cookies set by other sites to help us deliver content from their services.
You have accepted additional cookies. You can change your cookie settings at any time.
You have rejected additional cookies. You can change your cookie settings at any time.
Departments, agencies and public bodies
News stories, speeches, letters and notices
Detailed guidance, regulations and rules
Reports, analysis and official statistics
Consultations and strategy
Data, Freedom of Information releases and corporate reports
Actions that parallel exporters to the EEA and intellectual property rights holders need to take.
How to get a parallel import licence for your medicine in the UK, including pharmacovigilance requirements and submitting your application.
Parallel import licences granted in 2025.
The process to convert Parallel Distribution Notices (PDNs) into Parallel Import Licences (PILs)
Parallel import licences granted in 2024
Parallel import (PLPI) licences granted since January 2014.
Information for wholesale dealer licence holders about the medicines put on the UK market for UK patients that they cannot export or hoard.
Information relating to parallel imports and the implementation of the Windsor Framework.
Guidance for the pharmaceutical industry on how to apply for an authorisation to place a veterinary medicine on the UK market or part of, or to expire one.
Don’t include personal or financial information like your National Insurance number or credit card details.
To help us improve GOV.UK, we’d like to know more about your visit today. Please fill in this survey (opens in a new tab and requires JavaScript).